When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
IONS - Bicycle Therapeutics: An Oncology Play With Big Potential
Ionis Pharmaceuticals Inc.
BT8009 test results conformed to preliminary data suggesting it to be an effective treatment for tumors.
BT7480 is currently advancing its phase I clinical trials, and CEO Dr. Kevin Lee said he is pleased with the progress.
Bicycle recently reached a partnership with both Roche and Ionis Pharmaceuticals, offering encouragement regarding drug viability to increase treatment response rates for cancer patients.